Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic Treatments

NCT05769868 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1000

Enrollment

OTHER_GOV

Sponsor class

Conditions

Cirrhosis
Diabetes Mellitus
Oncologic Disorders

Interventions

DRUG: Esmolol Injection [Brevibloc]

Sponsor

Consorcio Centro de Investigación Biomédica en Red (CIBER)

Collaborators

[object Object]